Granules India appoints Ramraj Rangarajulu as President and Head - Formulations Operations
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
e brings over 27+ years of rich pharmaceutical experience
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Need to harmonize traditional and modern medicine to combat alarming health problems
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
Subscribe To Our Newsletter & Stay Updated